4D Presents at IHMC 2018 |
June 27, 2018 | June 2018 Bond Updates |
LEEDS, England, June 27, 2018 /PRNewswire/ --
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, today announced that the Company's Chief Scientific Officer, Dr. Alex Stevenson, has spoken at the International Human Microbiome... |
View more at: https://www.prnewswire.com/news-releases/4d-presents-at-ihmc-2018-686652161.html |
Related News |